Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

OBJECTIVE: To assess the efficacy and safety of hydroxychloroquine plus standard of care compared with standard of care alone in adults with coronavirus disease 2019 (covid-19). DESIGN: Multicentre, open label, randomised controlled trial. SETTING: 16 government designated covid-19 treatment centres...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Wei, Cao, Zhujun, Han, Mingfeng, Wang, Zhengyan, Chen, Junwen, Sun, Wenjin, Wu, Yaojie, Xiao, Wei, Liu, Shengyong, Chen, Erzhen, Chen, Wei, Wang, Xiongbiao, Yang, Jiuyong, Lin, Jun, Zhao, Qingxia, Yan, Youqin, Xie, Zhibin, Li, Dan, Yang, Yaofeng, Liu, Leshan, Qu, Jieming, Ning, Guang, Shi, Guochao, Xie, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221473/
https://www.ncbi.nlm.nih.gov/pubmed/32409561
http://dx.doi.org/10.1136/bmj.m1849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221473/
https://www.ncbi.nlm.nih.gov/pubmed/32409561
http://dx.doi.org/10.1136/bmj.m1849

Ejemplares similares